Through its venture capital arm Accenture Ventures, professional services company Accenture has invested in data-driven simulations provider Virtonomy to accelerate the time to market medical devices.
The investment will allow Virtonomy to extend its capabilities to medical technology companies and enhance medical device design.
The expenditure is part of Accenture Venture’s engagement and investment programme called Project Spotlight, which focuses on emerging technology software companies.
Accenture Ventures managing director Tom Lounibos said: “Digital twin technology, alongside data, analytics and AI, is opening the door to endless new possibilities to reinvent the life sciences industry.”
Virtonomy offers data-driven simulations, which use existing patient data and digital twin technology, to speed up the launch of medical devices into the market.
Medical device manufacturers can use the digital twin simulation solution to develop model patient virtual environments to test their devices in a cost-effective manner.
The solution is built on a database of real clinical data to reflect demographic diversity, anatomical variability and pathological conditions.
Existing data from clinical studies with children can be used by the digital twin simulation to provide virtual environments to evaluate the impact of medical devices.
Virtonomy co-founder and CEO Dr Simon Sonntag said: “Digital twin technology can help address these challenges, and tapping into Accenture’s expertise in data strategy and management will help Virtonomy expand our existing database of clinical data with essential data and actionable insights that can streamline the medical device manufacturing process.”
The company’s team includes experts in different fields such as medical engineering, clinical practice, image and data processing and visualisation.